11:58 AM EST - Valeant Pharmaceuticals International Inc. : said Thursday it will pay $76 million plus additional royalties to acquire the marketing rights to skin medications Elidel and Xerese for the U.S., Canada and Mexico markets. Valeant Pharmaceuticals International Inc.
shares VRX are trading off 97 cents at $50.04.
